, Columnist
Finally, Real Progress Against Pancreatic Cancer
New hope is in sight for one of the toughest cancers.
Graphic: Nemes Laszlo/Getty Images Plus
Every once in a while, an advance in treating cancer is so stunning that doctors get chills. Such is the case for Revolution Medicines’ pancreatic cancer therapy daraxonrasib, which in a late-stage study allowed patients with advanced disease to live twice as long as those who only received chemotherapy.
That’s an astounding advance for a cancer where experimental treatments have tended to offer progress measured in days or weeks, if at all. Giving patients and their families more months of time together — another birthday, another Christmas, a family reunion — would be truly meaningful.